Lu, Zhengzhao
Xiong, Yunyun
Yang, Kaixuan
Gu, Hongqiu
Duan, Chunmiao
Zhao, Xingquan
Meng, Xia
Wang, Yongjun
Article History
Received: 9 October 2022
Accepted: 9 December 2022
First Online: 19 January 2023
Declarations
:
: CNSR-III was approved by the Central Institutional Review Board in Beijing Tiantan Hospital (IRB approval number: KY2015–001-01), and written informed consents were obtained from all participants. Regarding vulnerable participants, the study obtained written informed consents from their legally authorized representatives for all vulnerable participants. All methods were performed in accordance with the principles expressed in the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.